HK1040620A1 - 治疗流感的肽基疫苗 - Google Patents
治疗流感的肽基疫苗 Download PDFInfo
- Publication number
- HK1040620A1 HK1040620A1 HK02102105.6A HK02102105A HK1040620A1 HK 1040620 A1 HK1040620 A1 HK 1040620A1 HK 02102105 A HK02102105 A HK 02102105A HK 1040620 A1 HK1040620 A1 HK 1040620A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- epitopes
- influenza
- epitope
- influenza virus
- hla molecules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12733198A IL127331A0 (en) | 1998-11-30 | 1998-11-30 | Peptide-based vaccine for influenza |
| IL12733198 | 1998-11-30 | ||
| PCT/IL1999/000640 WO2000032228A2 (en) | 1998-11-30 | 1999-11-28 | Peptide-based vaccine for influenza |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1040620A1 true HK1040620A1 (zh) | 2002-06-21 |
Family
ID=11072200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK02102105.6A HK1040620A1 (zh) | 1998-11-30 | 1999-11-28 | 治疗流感的肽基疫苗 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US6740325B1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1135159A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002531415A (cg-RX-API-DMAC7.html) |
| KR (1) | KR100703571B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE556719T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU766883B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR9915811A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2352454C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2204187T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2389611T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1040620A1 (cg-RX-API-DMAC7.html) |
| IL (3) | IL127331A0 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ511918A (cg-RX-API-DMAC7.html) |
| PT (1) | PT2204187E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000032228A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
| WO2002026252A1 (en) * | 2000-08-10 | 2002-04-04 | Tsinghua University | A vaccine for influenza virus and its preparation |
| FI20031536A0 (fi) * | 2003-10-20 | 2003-10-20 | Biotie Therapies Oyj | Korkean affiniteetin ligandit influenssavirukselle ja menetelmät niiden valmistamiseen |
| PL1692265T3 (pl) | 2003-11-04 | 2011-12-30 | The Administrators Of The Tulane Educational Fund | Sposób zapobiegania fuzji wirus:komórka przez hamowanie działania regionu inicjowania fuzji w wirusach RNA zawierających fuzogenne błonowe białka otoczki klasy I |
| GB0716992D0 (en) * | 2007-08-31 | 2007-10-10 | Immune Targeting Systems Its L | Influenza antigen delivery vectors and constructs |
| WO2006074303A2 (en) * | 2005-01-05 | 2006-07-13 | Philadelphia Health And Education Corporation | Delivery vehicles, bioactive substances and viral vaccines |
| AR052195A1 (es) | 2005-01-19 | 2007-03-07 | Vaxinnate Corp | Composiciones de patrones moleculares asociados a patogenos en metodos de uso |
| FI20060200A0 (fi) * | 2005-04-20 | 2006-02-27 | Glykos Finland Oy | Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi |
| KR20080027777A (ko) * | 2005-06-01 | 2008-03-28 | 배리에이션 바이오테크놀로지스 아이엔씨. | 펩티드기초 인플루엔자 백신 제제 |
| US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| US7468187B2 (en) * | 2005-10-18 | 2008-12-23 | Iowa State University Research Foundation, Inc. | Canine influenza virus and related compositions and methods of use |
| US20090169576A1 (en) * | 2005-10-26 | 2009-07-02 | Roberto Crea | Influenza combinatorial antigen vaccine |
| AU2006311752A1 (en) * | 2005-11-07 | 2007-05-18 | Sidney Kimmel Cancer Center | CD40 ligand fusion protein vaccine |
| DK1968632T3 (da) | 2005-12-06 | 2012-07-16 | Yeda Res & Dev | Forbedret influenzavaccine |
| PL2478916T3 (pl) * | 2006-01-27 | 2020-11-16 | Seqirus UK Limited | Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy |
| GB0613977D0 (en) | 2006-02-07 | 2006-08-23 | Peptcell Ltd | Peptide sequences and compositions |
| ES2555544T3 (es) * | 2006-03-07 | 2016-01-04 | Vaxinnate Corporation | Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas |
| US20080208486A1 (en) * | 2006-03-23 | 2008-08-28 | Jari Natunen | Integrated System, Device and Use Thereof |
| US8222204B2 (en) | 2006-05-03 | 2012-07-17 | The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC | Influenza inhibiting compositions and methods |
| US20110129438A1 (en) * | 2006-06-28 | 2011-06-02 | James Robert Swartz | Immunogenic protein constructs |
| FI20060946A0 (fi) * | 2006-10-26 | 2006-10-26 | Glykos Finland Oy | Influenssaviruksen nukleiinihappoja ja peptidejä |
| WO2008112218A2 (en) | 2007-03-12 | 2008-09-18 | Antigen Express, Inc. | Li-rnai involved li suppression in cancer immunotherapy |
| WO2009016639A2 (en) | 2007-08-02 | 2009-02-05 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope influenza vaccines |
| SG190562A1 (en) | 2008-04-18 | 2013-06-28 | Vaxinnate Corp | Deletion mutants of flagellin and methods of use |
| CA2721800A1 (en) | 2008-04-21 | 2009-10-29 | Nanobio Corporation | Nanoemulsion influenza vaccine |
| JP2011519834A (ja) * | 2008-04-25 | 2011-07-14 | インスティチュート フォー システムズ バイオロジー | フラジェリンポリペプチドワクチン |
| WO2009135152A2 (en) | 2008-05-02 | 2009-11-05 | University Of Rochester | Arrayed detector system for measurement of influenza immune response |
| WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
| MX2012000372A (es) | 2009-07-06 | 2012-02-28 | Variation Biotechnologies Inc | Metodos para preparar vesiculas y formulaciones producidas a partir de las mismas. |
| US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| CA2840079C (en) | 2010-07-06 | 2018-07-03 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
| AU2012205315B2 (en) | 2011-01-13 | 2017-05-04 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
| US10736844B2 (en) | 2011-01-13 | 2020-08-11 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
| WO2012114323A1 (en) | 2011-02-22 | 2012-08-30 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| CA2840982C (en) | 2011-07-06 | 2022-06-07 | Vira BITKO | Human respiratory syncytial virus vaccine |
| JP6205360B2 (ja) | 2011-08-22 | 2017-09-27 | ナノバイオ コーポレーション | 単純ヘルペスウイルスのナノエマルジョンワクチン |
| WO2013072768A2 (en) | 2011-11-18 | 2013-05-23 | Variation Biotechnologies, Inc. | Synthetic derivatives of mpl and uses thereof |
| CA2894442C (en) | 2012-01-12 | 2020-01-21 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
| EP4008354A1 (en) | 2012-01-27 | 2022-06-08 | Variation Biotechnologies Inc. | Methods and compositions for therapeutic agents |
| US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
| CN103961307B (zh) | 2013-02-05 | 2019-11-29 | 日东电工株式会社 | 经皮给予用wt1肽癌症疫苗组合物 |
| CA2840997A1 (en) | 2013-02-05 | 2014-08-05 | Nitto Denko Corporation | Vaccine composition for transdermal administration |
| CN103961701B (zh) | 2013-02-05 | 2018-09-14 | 日东电工株式会社 | 疫苗组合物 |
| CA2840954A1 (en) | 2013-02-05 | 2014-08-05 | Nitto Denko Corporation | Vaccine composition for transdermal or mucosal administration |
| CA2840937A1 (en) | 2013-02-05 | 2014-08-05 | Nitto Denko Corporation | Vaccine composition for transdermal administration |
| CN103961700A (zh) | 2013-02-05 | 2014-08-06 | 日东电工株式会社 | 粘膜给予用疫苗组合物 |
| CA2841014A1 (en) | 2013-02-05 | 2014-08-05 | Nitto Denko Corporation | Tape preparation of wt1 peptide cancer vaccine for transdermal administration |
| CA2840941A1 (en) | 2013-02-05 | 2014-08-05 | Nitto Denko Corporation | Wt1 peptide cancer vaccine composition for transdermal administration |
| CN103961702B (zh) | 2013-02-05 | 2019-04-09 | 日东电工株式会社 | 粘膜给予用wt1肽癌症疫苗组合物 |
| CN103961697A (zh) | 2013-02-05 | 2014-08-06 | 日东电工株式会社 | 粘膜给予用疫苗组合物 |
| RU2531235C2 (ru) * | 2013-02-15 | 2014-10-20 | Общество с ограниченной ответственностью "Универсальные БиоСистемы" (ООО "УБС") | Поливалентная вакцина против гриппа на основе гибридного белка |
| CN103901202B (zh) * | 2014-04-04 | 2015-08-12 | 中国人民解放军成都军区疾病预防控制中心 | 基于共有表位甲型流感病毒抗体通用型竞争性elisa检测方法 |
| CN106687138B (zh) | 2014-09-03 | 2021-10-15 | 日东电工株式会社 | 包含双膦酸盐剂的细胞性免疫用疫苗药物组合物 |
| EP3189852B1 (en) | 2014-09-03 | 2021-04-07 | Nitto Denko Corporation | Bisphosphonate-containing pharmaceutical vaccine composition for humoral immunity |
| WO2017022793A1 (ja) | 2015-08-06 | 2017-02-09 | 日東電工株式会社 | 免疫誘導促進組成物及びワクチン医薬組成物 |
| BR112019013402A2 (pt) * | 2016-12-28 | 2020-03-03 | Invvax, Inc. | Vacinas de influenza |
| WO2026101847A1 (en) | 2024-11-05 | 2026-05-15 | Bluewillow Biologics, Inc. | Methods of influenza vaccination and compositions for the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL61904A (en) | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
| IL101639A0 (en) | 1992-04-17 | 1992-12-30 | Yeda Res & Dev | Recombinant influenza vaccines |
| WO1997044667A2 (fr) * | 1996-05-21 | 1997-11-27 | Institut Pasteur | Methodes d'utilisation de complexes peptide/complexe majeur d'histocompatibilite pour obtenir ou purifier des cellules t antigene-specifiques et pour stimuler des cellules t |
| IL127331A0 (en) * | 1998-11-30 | 1999-09-22 | Yeda Res & Dev | Peptide-based vaccine for influenza |
-
1998
- 1998-11-30 IL IL12733198A patent/IL127331A0/xx unknown
-
1999
- 1999-11-28 WO PCT/IL1999/000640 patent/WO2000032228A2/en not_active Ceased
- 1999-11-28 EP EP99972929A patent/EP1135159A2/en not_active Withdrawn
- 1999-11-28 EP EP10003160A patent/EP2204187B1/en not_active Expired - Lifetime
- 1999-11-28 HK HK02102105.6A patent/HK1040620A1/zh unknown
- 1999-11-28 US US09/856,920 patent/US6740325B1/en not_active Expired - Lifetime
- 1999-11-28 DK DK10003160.8T patent/DK2204187T3/da active
- 1999-11-28 PT PT10003160T patent/PT2204187E/pt unknown
- 1999-11-28 BR BR9915811-6A patent/BR9915811A/pt not_active IP Right Cessation
- 1999-11-28 AT AT10003160T patent/ATE556719T1/de active
- 1999-11-28 NZ NZ511918A patent/NZ511918A/en not_active IP Right Cessation
- 1999-11-28 CA CA2352454A patent/CA2352454C/en not_active Expired - Lifetime
- 1999-11-28 ES ES10003160T patent/ES2389611T3/es not_active Expired - Lifetime
- 1999-11-28 AU AU14066/00A patent/AU766883B2/en not_active Expired
- 1999-11-28 JP JP2000584919A patent/JP2002531415A/ja active Pending
- 1999-11-28 KR KR1020017006639A patent/KR100703571B1/ko not_active Expired - Lifetime
- 1999-11-28 IL IL14336799A patent/IL143367A0/xx active IP Right Grant
-
2001
- 2001-05-24 IL IL143367A patent/IL143367A/en not_active IP Right Cessation
-
2004
- 2004-05-17 US US10/846,548 patent/US7192595B2/en not_active Expired - Lifetime
-
2007
- 2007-02-07 US US11/672,429 patent/US7514086B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL143367A (en) | 2006-09-05 |
| HK1145448A1 (en) | 2011-04-21 |
| KR20010089512A (ko) | 2001-10-06 |
| ATE556719T1 (de) | 2012-05-15 |
| NZ511918A (en) | 2003-08-29 |
| AU1406600A (en) | 2000-06-19 |
| PT2204187E (pt) | 2012-08-10 |
| US7514086B2 (en) | 2009-04-07 |
| AU766883B2 (en) | 2003-10-23 |
| CA2352454A1 (en) | 2000-06-08 |
| EP2204187B1 (en) | 2012-05-09 |
| WO2000032228A3 (en) | 2000-10-05 |
| EP2204187A1 (en) | 2010-07-07 |
| JP2002531415A (ja) | 2002-09-24 |
| US20050002954A1 (en) | 2005-01-06 |
| US20070122424A1 (en) | 2007-05-31 |
| IL143367A0 (en) | 2002-04-21 |
| US6740325B1 (en) | 2004-05-25 |
| CA2352454C (en) | 2013-02-05 |
| BR9915811A (pt) | 2001-08-21 |
| IL127331A0 (en) | 1999-09-22 |
| US7192595B2 (en) | 2007-03-20 |
| EP1135159A2 (en) | 2001-09-26 |
| KR100703571B1 (ko) | 2007-04-05 |
| ES2389611T3 (es) | 2012-10-29 |
| DK2204187T3 (da) | 2012-08-20 |
| WO2000032228A2 (en) | 2000-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000032228A3 (en) | Peptide-based vaccine for influenza | |
| JP2002531415A5 (cg-RX-API-DMAC7.html) | ||
| Liu et al. | High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity | |
| Schild et al. | Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. | |
| UY27552A1 (es) | 17a- alquil- 17b- oxi-estratrienos y productos intermediarios para su preparacinn, uso de los 17a-alquil-17b-oxi-estratrienos para obtener medicamentos y preparados farmacéuticos. | |
| SE9704545D0 (sv) | Novel compounds | |
| EE200000378A (et) | Adamantaani derivaadid | |
| WO2003076603A3 (en) | Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions | |
| CA2164818A1 (en) | Tandem synthetic hiv-1 peptides | |
| ES2619332T3 (es) | Fosfatasa alcalina dirigida al hueso, kits y métodos de uso de la misma | |
| DK0528859T3 (da) | Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer | |
| DE69533594D1 (de) | Präparate und verfahren zum auslösen von ctl-immunität | |
| NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
| BR0009580A (pt) | Composição, processos para preparar vìrus da influenza, para preparar um veìculo de liberação de genes, para preparar vìrus da influenza defeituosos de replicação infecciosa, para imunizar um paciente contra um patógeno, para preparar vìrus infeccioso, e para preparar vìrus, vìrus, célula, vetor, célula hospedeira, e, uso do vìrus | |
| IL150602A (en) | Proteosome influenza vaccine, method for preparing such and use thereof | |
| DE69939327D1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| MY125978A (en) | Admantane derivatives | |
| DK0712426T3 (da) | Fluorescerende latex, som omfatter i det mindste to fluorokromer, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
| AU4622693A (en) | Potentiation of immunogenic response | |
| WO1994026903A3 (en) | Human influenza virus peptides binding hla-i molecule | |
| SE8604991L (sv) | Tillvexthemmande peptid fran ormgift | |
| DK0707473T3 (da) | Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler | |
| CA2521038A1 (en) | Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production | |
| ATE208421T1 (de) | Stimulierung der immunantwort durch virales protein | |
| DE3370477D1 (en) | Acetylcysteine salts, their preparation and use |